SCHEMBL4899751

SCHEMBL4899751

COc1ccc(N)c(-c2ncco2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 1/20 0.46
▸ NOS1 P29475 1/20 0.46
▸ NOS2 P35228 1/20 0.46
▸ HCRTR1 O43613 1/20 0.43
▸ HCRTR2 O43614 1/20 0.43
▸ CFTR P13569 1/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ DYRK1A Q13627 3/20 0.41
▸ CCR1 P32246 1/20 0.41
▸ CCR5 P51681 1/20 0.41
▸ CCR8 P51685 1/20 0.41
▸ LTA4H P09960 1/20 0.40
▸ MEN1 O00255 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4894191 0.85 NPC1 (0.46) CFTRCYP3A4ALDH1A1CYP1A2CYP2D6
SCHEMBL14108017 0.83 HCRTR1 (0.46) NOS3NOS1NOS2HCRTR1HCRTR2
SCHEMBL27895619 0.83 ALDH1A1 (0.52) HCRTR1HCRTR2ALDH1A1CCR1CCR5
SCHEMBL27895648 0.79 ALDH1A1 (0.51) HCRTR1HCRTR2CYP3A4ALDH1A1CYP1A2
SCHEMBL14084344 0.79 HCRTR1 (0.41) NOS3NOS1NOS2HCRTR1HCRTR2
SCHEMBL17392495 0.78 HSP90AA1 (0.44) NOS3NOS1NOS2HCRTR1HCRTR2
SCHEMBL4823648 0.76 NPC1 (0.44) HCRTR1HCRTR2ALDH1A1MEN1MAPT
SCHEMBL21054194 0.76 IDO1 (0.45) CFTRCYP1A2LTA4HMEN1MAPT
SCHEMBL30206743 0.75 ALDH1A1 (0.61) NOS3NOS1NOS2CYP3A4ALDH1A1
SCHEMBL30206740 0.75 ALDH1A1 (0.61) NOS3NOS1NOS2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132551-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2008-06-05 — — US disclosed
EP-1611128-A2 POSITIVE ALLOSTERIC MODULATORS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR Pharmacia & Upjohn Company LLC (US) 2006-01-04 — — EP disclosed
WO-2004085433-A2 POSITIVE ALLOSTERIC MODULATORS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR PHARMACIA & UPJOHN COMPANY LLC (US) 2004-10-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132551-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNA7, CHRNA5 NOS3 3695/4885NOS1 3010/4885NOS2 4162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback